Politics, Policy & Law

<div class="articleContainer"><div class="articleWrapper"><div class="articleContent"><h1 class="text title">Calming the pendulum</h1><h2 class="title-bottom webtitle">What industry, FDA must do to realize the potential of patient engagement</h2><div class="byline">Steve Usdin, Washington Editor</div><div class="date"></div></div></div></div>

cancer

Endocrine / Metabolic

Musculoskeletal

Neurology

Calming the pendulum

Why patient engagement is the top priority for PDUFA reauthorization and the 21st Century Cures initiative. 

What industry, FDA must do to realize the potential of patient engagement

Featured Analysis

Articles by Category

Current Editions

Data Graphics

Distillery

Podcasts & Webcasts

Special Reports & Presentations

White Papers

Analysis

BCIQ

Company Profiles

Product Profiles

Target Profiles

Financial Dashboards

BCIQ Data

All Events

China Healthcare Summit

Bio€quity Europe

The BioCentury Show

Events

My Workspace

Company Overview

Management

Analysts & Research Team

Scientific Advisory Board

About BioCentury

Contact Us

Forgot Password

Trial

Subscribe

Advertising & Sponsorship

Career Opportunities

Customer Resource Center

Contact

Home

<br/><br/><center><span style="font-size:1.75rem;font-weight:500;">Access this Article</span></center>